NEW YORK, Jan. 14, 2023 (GLOBE NEWSWIRE) —

Duck Creek Technologies, Inc. DCT

Lifshitz Law PLLC Announces an investigation into a possible breach of fiduciary duties in connection with the sale of DCT to Vista Equity Partners for $19.00 per share in cash.

If you are a DCT investor and would like additional information about our research, please fill out Information Request Form or contact Joshua Lifshitz, Esq. by phone at (516) 493-9780 or by email info@lifshitzlaw.com.

Paya Holdings Inc. PAYA

Lifshitz Law PLLC Nuvei Corp. Announces Investigation into Possible Breach of Fiduciary Duties in Connection with Sale of PAYA for $9.75 per share in cash.

If you are a PAYA investor and would like additional information about our investigation, please fill out Information Request Form or contact Joshua Lifshitz, Esq. by phone at (516) 493-9780 or by email info@lifshitzlaw.com.

Albireo Pharma, Inc. ALBO

Lifschitz LawPLC announces an investigation into a possible breach of fiduciary duty in connection with the sale of ALBO to Ipsen, in which Ipsen would acquire ALBO for $42.00 per share in cash plus a contingent value right per share (CVR) entitling its holder to deferred cash payments of $10.00 per CVR granted payable upon approval of Bylvay by the US Food and Drug Administration for the indication of biliary atresia by December 31, 2027.

If you are an ALBO investor and would like more information about our investigation, please fill out Information Request Form or contact Joshua Lifshitz, Esq. by phone at (516) 493-9780 or by email info@lifshitzlaw.com.

Amryt Pharma Plc AMYT

Lifshitz Law PLLC announces an investigation into a possible breach of fiduciary duty in connection with the sale of AMYT to Chiesi Farmaceutici SpA, whereby Chiesi paid AMYT in cash for $14.50 per American Depositary Share (ADS) of AMYT plus contingent stock rights of up to $2.50 $ per ADS payable when Certain milestones related to AMYT’s product Filsuvez® are…